TCIM
ATRS

TIAA CREF Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

TIAA CREF Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$919K Buy
303,448
+21,242
+8% +$68.8K ﹤0.01% 2359
2018
Q4 		$768K Sell
282,206
-24,160
-8% -$79.6K ﹤0.01% 2385
2018
Q3 		$1.03M Sell
306,366
-9,263
-3% -$28.6K ﹤0.01% 2408
2018
Q2 		$814K Sell
315,629
-25,028
-7% -$62.3K ﹤0.01% 2579
2018
Q1 		$749K Sell
340,657
-17,321
-5% -$39K ﹤0.01% 2575
2017
Q4 		$712K Sell
357,978
-9,169
-2% -$20K ﹤0.01% 2629
2017
Q3 		$1.19M Sell
367,147
-21,208
-5% -$65.4K ﹤0.01% 2439
2017
Q2 		$1.25M Buy
+388,355
New +$1.1M ﹤0.01% 2436
2016
Q2 		– Sell
-471,209
Closed -$410K – 3210
2016
Q1 		$410K Buy
471,209
+9,951
+2% +$9.63K ﹤0.01% 2839
2015
Q4 		$558K Hold
461,258
– – ﹤0.01% 2858
2015
Q3 		$784K Hold
461,258
– – ﹤0.01% 2716
2015
Q2 		$959K Buy
461,258
+49,588
+12% +$120K ﹤0.01% 2715
2015
Q1 		$1.12M Buy
411,670
+4,502
+1% +$11.4K ﹤0.01% 2558
2014
Q4 		$1.05M Sell
407,168
-22,695
-5% -$51K ﹤0.01% 2625
2014
Q3 		$787K Sell
429,863
-26,334
-6% -$57.4K ﹤0.01% 2773
2014
Q2 		$1.22M Buy
456,197
+18,872
+4% +$56.8K ﹤0.01% 2595
2014
Q1 		$1.53M Sell
437,325
-17,490
-4% -$77.6K ﹤0.01% 2394
2013
Q4 		$2.04M Hold
454,815
– – ﹤0.01% 2243
2013
Q3 		$1.85M Sell
454,815
-152,496
-25% -$666K ﹤0.01% 2256
2013
Q2 		$2.53M Buy
+607,311
New +$2.35M ﹤0.01% 2015

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Investment Management's ATRS Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Antares Pharma, Inc. (ATRS) stake by 7.5% in Q1 2019, buying an estimated $68.8K and bringing the position to 303,448 shares worth $919K. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

TIAA CREF Investment Management first reported a position in ATRS in Q2 2013 and has held it in 20 quarters since. The position peaked at $2.53M in Q2 2013. 132 funds tracked by Wall St. Rank hold ATRS as of Q1 2019.

  • TIAA CREF Investment Management held 303,448 shares of Antares Pharma, Inc. worth $919K as of Q1 2019.
  • TIAA CREF Investment Management bought 21,242 Antares Pharma, Inc. shares in Q1 2019, an estimated $68.8K.
  • Antares Pharma, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2359 holding.
  • TIAA CREF Investment Management first reported a position in Antares Pharma, Inc. in Q2 2013 and has held it in 20 quarters since.
  • TIAA CREF Investment Management's Antares Pharma, Inc. position peaked at $2.53M in Q2 2013.
  • 132 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.